Latest News and Press Releases
Want to stay updated on the latest news?
-
DGAP-News: G-Therapeutics / Key word(s): Financing G-Therapeutics raises EUR 36 million to develop novel neuro-stimulation therapy for spinal cord injury 19.04.2016 / 08:00 The issuer is solely...
-
Vilnius, Lithuania, 2016-04-19 08:00 CEST (GLOBE NEWSWIRE) -- OMX Baltic Benchmark Fund share price on April 18 2016 – 8.3534 EUR OMX Baltic Benchmark Fund number of shares issued on April 18,...
-
Orkla will report its first quarter 2016 results on Tuesday, 3 May 2016 at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com. The...
-
Nanterre (France), April 19, 2016 Signature of definitive agreement for divestiture of Faurecia Automotive Exteriors business to Plastic Omnium Faurecia today signed the definitive agreement...
-
Yara International ASA first quarter 2016 results will be released on Thursday 21 April 2016. The results will be available at www.yara.com from 08:00 CEST.The results will be presented at 09:30...
-
Lehdistötiedote 19.4.2016 Huhtamäki laajentaa Venäjällä Huhtamäki vahvistaa asemaansa Venäjän johtavana kananmunapakkausten valmistajana investoimalla Ivanteevkan tuotantolaitoksella. Investointi on...
-
Petrobras has terminated the contract for Havila Fortress. The contract was blocked by local tonnage and the Certificate needed for operation in Brazil was not renewed. The terminated contract...
-
GWS is establishing a subsidiary, GWS Production (Singapore) Private Limited, in Singapore, in order to get closer to the market and the Asian customers. Since last year the company is represented...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FIT Biotech Oy Company release April 19, 2016 at...
-
In the first quarter, Byggmax increased net sales by +30% and new financial targets have been set January 1 - March 31 · Net sales amounted to SEK 737.9 M (570.0) up 29.5 percent. Pro forma...